ADENOSINE (Adenocard)

Name: ADENOSINE (AdenocardR)
Classification: Antiarrhythmic: 
  • Produces short acting AV block to aid in the diagnosis of supraventricular tachycardias
  • Drug of choice for acute conversion of SVT (all ages).
Dose:

Bolus Dose:

  • Administer each dose into a port as close to the patient as possible.
  • Administer each dose undiluted by IV direct. Administer within 1-2 seconds.
  • After each IV direct dose, administer a 20 mL sodium chloride 0.9% flush. Administer the flush as quickly as possible.


First dose:
6 mg IV direct by rapid bolus

Second dose if no response within 1-2 minutes:
12 mg IV direct by rapid bolus

Third dose if no response within 1-2 minutes:
12 mg IV direct by rapid bolus

Maximum total dose of 30 mg.

Administration: IV Infusion:
  • Not given by IV infusion
Contraindications:
  • Atrial flutter or fibrillation
  • Ventricular tachycardia
  • Known bronchospastic/bronchoconstrictive diseases (e.g. asthma)
  • Symptomatic bradycardia, sick sinus syndrome, second or complete AV block (unless a functioning pacemaker)
Adverse Effects:
  • cardiovascular
    • Symptoms associated with brief ventricular standstill (lightheaded, hypotension, flushing, nausea)
    • Sinus bradycardia, sinus arrest, atrial fibrillation, AV block (usually < 1 minute)
  • non-cardiovascular
    • Metallic taste
    • Blurred vision
    • Dyspnea, shortness of breath, hyperventilation, bronchospasm
Drug Interactions:
  • adenosine + aminophylline/theophylline = decreased adenosine effect
  • adenosine + digoxin = bradycardias and increased AV blocks
  • adenosine + verapamil = bradycardias and increased AV blocks
  • adenosine + beta blockers = bradycardias and increased AV blocks
Monitoring Therapy:
  • Continuous heart rate and cardiac rhythm
  • Blood pressure
Adult Critical Care Protocol:
  • May be administered IV direct by an Adult Critical Care Nurse.
  • A physician must be present during administration.
  • This drug must be given by rapid IV direct bolus with immediate flush. 
  • Resuscitation equipment must be available. 


Lynne Kelly, Pharmacist, CCTC
Brenda Morgan, Clinical Nurse Specialist, CCTC

Previous Update: September 17, 2018
Last Revised: February 13, 2023 (BM)